{"id":56265,"date":"2024-10-08T10:22:42","date_gmt":"2024-10-08T14:22:42","guid":{"rendered":"https:\/\/www.businessupturn.com\/usa\/?p=56265"},"modified":"2024-10-08T10:22:42","modified_gmt":"2024-10-08T14:22:42","slug":"cassava-sciences-surges-by-8-following-positive-phase-3-trial-news","status":"publish","type":"post","link":"https:\/\/www.businessupturn.com\/usa\/cassava-sciences-surges-by-8-following-positive-phase-3-trial-news\/56265\/","title":{"rendered":"Cassava Sciences surges by 8% following positive Phase 3 Trial news"},"content":{"rendered":"<p>Cassava Sciences Inc. (Nasdaq: SAVA) saw its stock jump by 8.6% in early trading after announcing the completion of dosing in the ReTHINK Phase 3 clinical trial, which included 804 patients. This milestone marks a significant step forward in the development of simufilam, the company\u2019s leading Alzheimer\u2019s drug candidate.<\/p>\n<p>Alongside the clinical update, Cassava\u2019s settlement with the SEC further cleared the path for simufilam\u2019s continued development. This agreement also follows internal governance changes, which aim to bolster the company\u2019s operational integrity amid heightened scrutiny.<\/p>\n<p>Cassava Sciences has been a key player in the biotech sector, particularly with its focus on addressing Alzheimer\u2019s disease through innovative treatments. With the completion of the ReTHINK trial, investors are optimistic about the future prospects of simufilam, and this reflects in the company\u2019s strong stock performance today.<\/p>\n<p>This recent surge puts Cassava Sciences on the radar of investors as they await further updates on the efficacy and safety results of the trial.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cassava Sciences Inc. (Nasdaq: SAVA) saw its stock jump by 8.6% in early trading after announcing the completion of dosing\u2026<\/p>\n","protected":false},"author":432,"featured_media":56326,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73],"tags":[20045],"class_list":["post-56265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-us-markets","tag-cassava-sciences"],"reading_time":"1 min read","_links":{"self":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/56265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/users\/432"}],"replies":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/comments?post=56265"}],"version-history":[{"count":0,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/56265\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media\/56326"}],"wp:attachment":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media?parent=56265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/categories?post=56265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/tags?post=56265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}